Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5734224 | Journal of Surgical Research | 2017 | 9 Pages |
Abstract
PSK treatment preferentially confers a survival gain for patients with stage IIIA/IIIB gastric cancer, especially in the PD-L1 (â) subpopulation.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Jun-Te MD, Chih-Sin PhD, Puo-Hsien MD, Tse-Ching MD, PhD, Wen-Chi MD, Chun-Yen MD, PhD, Ta-Sen MD, PhD,